Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Inhibitors of TNF-alpha production/release in early development at Sumitomo

Nov. 12, 1999

Synvisc under study for osteoarthritis of the hip

Nov. 11, 1999

Important new indication for Remicade approved by FDA

Nov. 11, 1999

Pfizer discovers new compounds that inhibit MMPs and other related enzymes

Nov. 9, 1999

BioSpecifics announces results of injectable collagenase phase II study

Nov. 8, 1999

Health Canada approves Vioxx for once-daily treatment of osteoarthritis

Nov. 5, 1999

Vertex commences pilot phase II study of VX-745 for rheumatoid arthritis

Nov. 4, 1999

Inhibitors of matrix metalloproteinase enzymes disclosed by HMR

Oct. 29, 1999

Collagenase-selective MMP inhibitors designed by British Biotech for arthritis

Oct. 28, 1999

Centocor submits sBLA to FDA for Remicade as treatment of rheumatoid arthritis

Oct. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...